Trefoil factor family peptides are increased in the saliva of children with mucositis

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 12, 2011, Pages 2051-2055

  Verey, Fran ^a   Nexo, Ebba ^b   Greenwood, Rosemary ^a   Berry, Monica ^a   Corfield, Anthony P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

ELIS.A.; Healthy children; Neutropenia; Oral mucositis; Saliva; Trefoil peptides

Indexed keywords

TREFOIL FACTOR FAMILY PEPTIDE 1; TREFOIL FACTOR FAMILY PEPTIDE 2; TREFOIL FACTOR FAMILY PEPTIDE 3; TREFOIL PEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER PATIENT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFANT; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN SECRETION; SALIVA; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; MUCOSITIS; PEPTIDES; SALIVA; TUMOR SUPPRESSOR PROTEINS;

LOTUS;

EID: 84856519285     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.667     Document Type: Article

References (31)

1. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: Unanswered questions. Oral Oncol 2003;39:91-100. (Pubitemid 36050914)
2. Sonis ST, Peterson DE, McGuire DB, Williams DA. Prevention of mucositis in cancer patients. J Natl Cancer Inst Monogr 2001;2001:1-2.
3. Cheng KK, Goggins WB, Lee VW, Thompson DR. Risk factors for oral mucositis in children undergoing chemotherapy: A matched case-control study. Oral Oncol 2008;44:1019-25.
4. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004;4:277-84. (Pubitemid 38525283)
5. Kjellev S. The trefoil factor family -small peptides with multiple functionalities. Cell Mol Life Sci 2009;66:1350-69.
6. Regalo G, Wright NA, Machado JC. Trefoil factors: From ulceration to neoplasia. Cell Mol Life Sci 2005;62:2910-5. (Pubitemid 43004743)
7. Poulsom R, Begos DE, Modlin IM. Molecular aspects of restitution: Functions of trefoil peptides. Yale J Biol Med 1996;69: 137-46. (Pubitemid 27172924)
8. Playford RJ. Trefoil peptides: What are they and what do they do? J R Coll Physicians Lond 1997;31:37-41. (Pubitemid 127463217)
9. Longman RJ, Thomas MG, Poulsom R. Trefoil peptides and surgical disease. Br J Surg 1999;86:740-8.
10. Podolsky DK. Mechanisms of regulatory peptide action in the gastrointestinal tract: Trefoil peptides. J Gastroenterol 2000; 35(Suppl 12):69-74. (Pubitemid 30229723)
11. Poulsen SS, Thulesen J, Hartmann B, Kissow HL, Nexo E, Thim L. Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats. Regul Pept 2003; 115:91-9. (Pubitemid 37289351)
12. Taupin D, Podolsky DK. Trefoil factors: Initiators of mucosal healing. Nat Rev Mol Cell Biol 2003;4:721-32. (Pubitemid 37082187)
13. Storesund T, Hayashi K, Kolltveit KM, Bryne M, Schenck K. Salivary trefoil factor 3 enhances migration of oral keratinocytes. Eur J Oral Sci 2008;116:135-40.
14. Wong WM, Poulsom R, Wright NA. Trefoil peptides. Gut 1999;44:890-5. (Pubitemid 29244230)
15. Siu LS, Romanska H, Abel PD, Baus-Loncar M, Kayademir T, Stamp GW, et al. TFF2 (trefoil family factor2) inhibits apoptosis in breast and colorectal cancer cell lines. Peptides 2004; 25:855-63. (Pubitemid 38721353)
16. Longman RJ, Douthwaite J, Sylvester PA, Poulsom R, Corfield AP, Thomas MG, et al. Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut 2000;47:792-800.
17. Ota H, Hayama M, Momose M, El-Zimaity HM, Matsuda K, Sano K, et al. Co-localization of TFF2 with gland mucous cell mucin in gastric mucous cells and in extracellular mucous gel adherent to normal and damaged gastric mucosa. Histochem Cell Biol 2006;126:617-25. (Pubitemid 44484906)
18. Thim L, Madsen F, Poulsen SS. Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 2002; 32:519-27. (Pubitemid 36223422)
19. Devine DA, High AS, Owen PJ, Poulsom R, Bonass WA. Trefoil factor expression in normal and diseased human salivary glands. Hum Pathol 2000;31:509-15. (Pubitemid 30262875)
20. Jagla W, Wiede A, Hinz M, Dietzmann K, Gulicher D, Gerlach KL, et al. Secretion of TFF-peptides by human salivary glands. Cell Tissue Res 1999;298:161-6. (Pubitemid 29460515)
21. Madsen J, Nielsen O, Tornoe I, Thim L, Holmskov U. Tissue localization of human trefoil factors 1, 2, and 3. J Histochem Cytochem 2007;55:505-13. (Pubitemid 46668632)
22. Storesund T, Schreurs O, Messelt EB, Kolltveit KM, Schenck K. Trefoil factor family 3 expression in the oral cavity. Eur J Oral Sci 2009;117:636-43.
23. Samson MH, Chaiyarit P, Nortvig H, Vestergaard EM, Ernst E, Nexo E. Trefoil factor family peptides in human saliva and cyclical cervical mucus. Method evaluation and results on healthy individuals. Clin Chem Lab Med 2011;49:861-8.
24. Vieten D, Corfield A, Carroll D, Ramani P, Spicer R. Impaired mucosal regeneration in neonatal necrotising enterocolitis. Pediatr Surg Int 2005;21:153-60. (Pubitemid 40468873)
25. Gibson F, Cargill J, Allison J, Begent J, Cole S, Stone J, et al. Establishing content validity of the oral assessment guide in children and young people. Eur J Cancer 2006;42:1817-25. (Pubitemid 44177568)
26. Glenny AM, Gibson F, Auld E, Coulson S, Clarkson JE, Craig JV, et al. The development of evidence-based guidelines on mouth care for children, teenagers and young adults treated for cancer. Eur J Cancer 2010;46:1399-412.
27. Vestergaard EM, Brynskov J, Ejskjaer K, Clausen JT, Thim L, Nexo E, et al. Immunoassays of human trefoil factors 1 and 2: Measured on serum from patients with inflammatory bowel disease. Scand J Clin Lab Invest 2004;64:146-56. (Pubitemid 38491386)
28. Vestergaard EM, Poulsen SS, Gronbaek H, Larsen R, Nielsen AM, Ejskjaer K, et al. Development and evaluation of an ELISA for human trefoil factor 3. Clin Chem 2002;48:1689-95.
29. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am 2008; 52:61-77.
30. Peterson DE, Barker NP, Akhmadullina LI, Rodionova I, Sherman NZ, Davidenko IS, et al. Phase II, randomized, doubleblind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracilbased chemotherapy. J Clin Oncol 2009;27:4333-8.
31. Caluwaerts S, Vandenbroucke K, Steidler L, Neirynck S, Vanhoenacker P, Corveleyn S, et al. AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis. Oral Oncol 2010;46:564-70.